Previous 10 | Next 10 |
There are a handful of companies that dominate the coronavirus vaccine market. The two leaders -- Pfizer and Moderna -- expect to generate a combined $55.5 billion in sales this year. Is there any room left in this space for newcomers? The answer is a resounding yes. First, vaccines...
Vaxart (NASDAQ: VXRT) soared to stardom when its shares advanced 1,500% last year. Why the excitement? The biotech company is developing a coronavirus-vaccine candidate in pill form. Investors realized such a product could win over those who cringe at the thought of needles. ...
New Duke University-led Study Shows That Vaxart's Oral COVID-19 Vaccine Candidate Reduces Airborne Transmission of SARS-CoV-2 Infection in Animal Model Data published in bioRxiv confirmed previous findings suggesting mucosal vaccines could reduce transmission of airborne viruses...
Shares of the developmental-stage biotech Vaxart (NASDAQ: VXRT) sank by 11.5% last month, according to data provided by S&P Global Market Intelligence . The biotech's stock has been sliding hard over the past month and half for two related reasons: Image source: Getty Im...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips When Merck (NYSE: MRK ) announced last week that it had an inexpensive antiviral oral drug to treat Covid-19, Vaxart (NASDAQ: VXRT ) plunged by almost 10%. For much of the year, VXRT stock moved nowhere. Bears hav...
Vaxart Begins Recruiting in Global Phase II COVID-19 Oral Tablet Vaccine Clinical Trial Start of US Phase II of S-Only Vaccine Candidate Expected Later This Month Ex-US Clinical Trials to Begin Later This Year with India Study PR Newswire SOUTH SAN FRA...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, vaccine stocks are once again in focus for investors. However, this time, the news isn’t as good as investors might hope to see. Source: shutterstock.com/PhotobyTawat Indeed, vaccine stocks such as ...
Good news for some companies often means bad news for others. That's what we're seeing Friday as the stocks of several COVID-19 vaccine makers sank following the announcement by Merck (NYSE: MRK) and Ridgeback Biotherapeutics of positive results from a late-stage study of an oral CO...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Based in California, Vaxart (NASDAQ: VXRT ) is a biotech company known for making vaccines. But there’s an unusual, differentiating angle here: its vaccines are orally administered. This is certainly inter...
Vaxart Appoints Dr. James F. Cummings as Chief Medical Officer Dr. Cummings Brings Nearly Three Decades of Experience to New Role PR Newswire SOUTH SAN FRANCISCO, Calif. , Sept. 27, 2021 /PRNewswire/ -- Vaxart, Inc. (NASDAQ: VXRT), today announced the ap...
News, Short Squeeze, Breakout and More Instantly...
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the second quarter ended June 30, 2024 after the market close on Thursd...
— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million — — Company well-capitalized to execute on multiple key clinical and regulatory milestones in COVID-19 and noroviru...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...